ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $649,000 | -6.6% | 6,984 | -40.2% | 0.00% | -50.0% |
Q3 2021 | $695,000 | -11.8% | 11,680 | +1.1% | 0.00% | 0.0% |
Q2 2021 | $788,000 | -2.5% | 11,556 | -0.9% | 0.00% | 0.0% |
Q1 2021 | $808,000 | -12.1% | 11,656 | -2.6% | 0.00% | -33.3% |
Q4 2020 | $919,000 | +15.0% | 11,971 | +12.0% | 0.00% | 0.0% |
Q3 2020 | $799,000 | +37.8% | 10,688 | +15.9% | 0.00% | +50.0% |
Q2 2020 | $580,000 | +83.0% | 9,218 | +21.8% | 0.00% | +100.0% |
Q1 2020 | $317,000 | +18.3% | 7,568 | +28.1% | 0.00% | 0.0% |
Q4 2019 | $268,000 | -0.4% | 5,908 | +0.2% | 0.00% | 0.0% |
Q3 2019 | $269,000 | -31.4% | 5,897 | -11.9% | 0.00% | -50.0% |
Q2 2019 | $392,000 | +41.5% | 6,693 | +8.3% | 0.00% | +100.0% |
Q1 2019 | $277,000 | +22.0% | 6,182 | +5.6% | 0.00% | 0.0% |
Q4 2018 | $227,000 | -15.6% | 5,852 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $269,000 | +15.0% | 5,852 | +9.3% | 0.00% | 0.0% |
Q2 2018 | $234,000 | +4.0% | 5,356 | -6.2% | 0.00% | 0.0% |
Q1 2018 | $225,000 | – | 5,707 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |